MedPath

Evaluation of the effect of Virechan and Shilajit in comparision to Thyroxine Sodium in the management of Hypothyroidism

Phase 1
Conditions
Health Condition 1: E039- Hypothyroidism, unspecified
Registration Number
CTRI/2024/01/062170
Lead Sponsor
Pt Khushilal Sharma Govt (Autonomous) Ayurveda College and Institute Bhopal (MP)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Newly diagnosed case of Hypothyroidism.

Patients age between 25 years to 45 years.

Patients those fit for Virechan Karma.

Exclusion Criteria

All complicated cases of Hypothyroidism, myxedema, severe mental illness, thyroid cancer etc. and other disease associated with endocrine imbalance.

Patients having chronic systemic illness.

Congenital hypothyroidism

Pregnant women and Lactating Mother.

Patients having undergone thyroid surgery.

Patients those unfit for Virechan Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath